Perryman Financial Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$549K Buy
1,515
+2
+0.1% +$685 0.07% 131
2026
Q1
$532K Buy
1,513
+24
+2% +$8.56K 0.08% 122
2025
Q4
$487K Buy
+1,489
New +$472K 0.07% 126

Other funds holding AMGN

Perryman Financial Advisory's AMGN Position: Q2 2026 in Review

Perryman Financial Advisory increased its Amgen (AMGN) stake by 0.13% in Q2 2026, buying an estimated $685 and bringing the position to 1,515 shares worth $549K. The position accounts for 0.07% of the portfolio, ranked #131.

Perryman Financial Advisory first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Perryman Financial Advisory held 1,515 shares of Amgen worth $549K as of Q2 2026.
  • Perryman Financial Advisory bought 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.07% of Perryman Financial Advisory's portfolio in Q2 2026, its #131 holding.
  • Perryman Financial Advisory first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Perryman Financial Advisory's 13F filing for Q2 2026, filed 24 Jul 2026.